Options: Show MedDRA Preferred Terms
| Side effect | Data for drug | Placebo | Labels |
|---|---|---|---|
| 1 | |||
| Anaphylactic shock | x | ||
| Angioedema | x | ||
| Asthma | x | ||
| Conjunctivitis | x | ||
| Cough | x | ||
| Cyanosis | x | ||
| Dyspnoea | x | ||
| Flushing | x | ||
| Hypotension | x | ||
| Pain | x | ||
| Pallor | x | ||
| Pruritus | x | ||
| Rhinitis | x | ||
| Sneezing | x | ||
| Swelling | x | ||
| Syncope | x | ||
| Tachycardia | x | ||
| Erythema | x | ||
| Urticaria | x | ||
| Wheezing | x | ||
| Oedema peripheral | x | ||
| Lacrimation | x | ||
| Bradycardia | x | ||
| Local reaction | x | ||
Information about indications was extracted from the indications and usage sections of the labels.
| Indication | Labels | ||
|---|---|---|---|
| Type I hypersensitivity | x | ||
standard – alternative
| 100% | ||
| 75% | ||
| 50% | ||
| 10% | ||
| frequent (1% to 100%) | ||
| infrequent (0.1% to 1%) | ||
| rare (<0.1%) | ||
| postmarketing | ||
| 0% | ||
| no frequency information | ||
| not found on label |